MAP2K7 and breast neoplasm: The most notable results are that the MEK_UP.V1_DN pathway was significantly enriched in breast tumors, whereas the MEK_UP.V1_UP pathway was enriched in ovarian, endometrial, and cervical tumors (Fig. 5a, b).